UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Parthenon LLC

Parthenon LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 546 shares of the healthcare conglomerate’s stock after buying an additional 60 shares during the period. Parthenon LLC’s holdings in UnitedHealth Group were worth $276,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the stock. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the 3rd quarter worth $37,000. DecisionPoint Financial LLC boosted its holdings in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after acquiring an additional 62 shares in the last quarter. Highline Wealth Partners LLC acquired a new stake in UnitedHealth Group in the third quarter valued at about $55,000. Finally, Legacy Investment Solutions LLC acquired a new position in UnitedHealth Group during the 3rd quarter worth approximately $57,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $510.75 on Thursday. The firm has a market capitalization of $470.03 billion, a price-to-earnings ratio of 32.95, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a 50 day moving average price of $520.62 and a 200 day moving average price of $561.67. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm earned $5.83 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages recently weighed in on UNH. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Oppenheimer lifted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Stephens raised their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. Finally, Barclays cut their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.